 <h1>Congratulations! 🎉 </h1>
    <p style="color:#637381;">All done! You’ve completed another milestone.</p>

To continue, please enter your email for authentication.

We’ve sent a 6‑digit code to #MAIL_ADDRESS#\nPlease check your inbox or spam folder and enter the code below to continue.

Verification code sent

Thank you for the payment. You can now access {collectionName} by simply clicking the button below.

Yes, you’ve successfully ordered! 🎉

Unlock This Exclusive Course

It seems that your email address is not currently on the authorized access list. Please ensure you are using the email address that was invited, or contact the content owner for assistance.

Verification Required for Access

Video: ICS Therapy Appropriateness in COPD

Question 1

Q1 Feedback

Question 2

Q2 Feedback

Selected Resources

Rate the Breaths Initiative

Learn when to initiate, continue, or withdraw inhaled corticosteroids in COPD based on exacerbations, eosinophil count, and asthma overlap.

5.5 ICS Therapy Appropriateness in COPD

<div class="simple-box-wrapper"><div class="simple-box"><div class="column" flex-size="undefined"><h3><span style="color:hsl(203,100%,30%);">🎯Learning Objective</span></h3><hr><p>By the end of this session, you will feel more confident at proactively assessing asthma control and identifing over-reliance on short-acting beta-agonists (SABA).</p><p>To complete this session, watch the video, answer the questions, and rate the IPCRG Breaths initiative.</p></div></div></div>